C5orf52: A Drug Target / Disease Biomarker (G100190949)

Target Name: C5orf52

NCBI ID: G100190949

C5orf52

Other Name(s): Chromosome 5 open reading frame 52 | CE052_HUMAN | Uncharacterized protein C5orf52 | chromosome 5 open reading frame 52

C5orf52: A Drug Target / Disease Biomarker

C5orf52 is a protein that is located in the cytoplasm of human cells. It is a member of the superfamily of proteins known as the kallikrein-related proteins (KLK) and is also known as KLK-related protein 52. This protein is of interest as a potential drug target or biomarker due to its unique structure and the studies that have been conducted on its function.

The protein encoded by the C5orf52 gene is a 12kDa protein that consists of 115 amino acid residues. It has a molecular weight of 13.9 kDa and a calculated pI of 2.8. The pI is the point at which the protein is able to interact with a specific ligand, such as a drug, and can form a stable complex. This means that if a drug was to bind to the C5orf52 protein, it would be able to interact with the protein and potentially disrupt its function.

One of the key features of the C5orf52 protein is its cytoplasmic localization. Unlike many other proteins, which are located in the nucleus or other organelles, C5orf52 is located in the cytoplasm. This is important because it allows the protein to interact with the cytoplasmic environment and perform its function in the cell.

Another feature of the C5orf52 protein is its structure. The protein has a unique 3D structure due to the presence of a hypervariable region (HVR) in the middle of the protein. The HVR is a region of the protein that is able to undergo structural changes in response to different environmental conditions, such as changes in temperature or the presence of a drug. This allows the protein to adapt to different environments and perform its function in the cell.

The C5orf52 protein has also been shown to play a role in several cellular processes, including cell signaling, cell adhesion, and cytoskeletal organization. For example, studies have shown that the C5orf52 protein can interact with the protein known as F-actinin and can influence the distribution of actinin in the cytoskeleton. This suggests that the C5orf52 protein may be involved in the regulation of cytoskeletal organization and the cytoskeleton, which is important for many cellular processes.

In addition to its role in cellular processes, the C5orf52 protein is also of interest as a potential drug target or biomarker due to its unique structure and the studies that have been conducted on its function. One of the main advantages of drug targets is that they are specific and can be targeted with small molecules or antibodies, which can make them easier to study and develop as treatments. The C5orf52 protein is a potential drug target due to its unique structure and the studies that have been conducted on its function, which may make it an attractive target for researchers to study further.

In conclusion, C5orf52 is a protein that is located in the cytoplasm of human cells and is of interest as a potential drug target or biomarker. Its unique structure and the studies that have been conducted on its function make it an attractive target for researchers to study further. Further research on the C5orf52 protein may reveal its role in cellular processes and its potential as a drug target or biomarker.

Protein Name: Chromosome 5 Open Reading Frame 52

The "C5orf52 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C5orf52 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets